头颈部癌的尿激酶型纤溶酶原激活物受体（uPAR）导向成像 - Suppr

Suppr

超能文献

uPAR directed-imaging of head-and-neck cancer.

作者信息

Baart Victor M, Boonstra Martin C, Sier Cornelis F M

机构信息

Leiden University Medical Center, Department of Surgery, Albinusdreef, Leiden, The Netherlands.

出版信息

Oncotarget. 2017 Mar 28;8(13):20519-20520. doi: 10.18632/oncotarget.16240.

DOI:10.18632/oncotarget.16240

PMID:28423554

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5400521/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45e8/5400521/68350560778d/oncotarget-08-20519-g001.jpg

相似文献

uPAR directed-imaging of head-and-neck cancer.

Oncotarget. 2017 Mar 28;8(13):20519-20520. doi: 10.18632/oncotarget.16240.

uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model.

Oncotarget. 2017 Feb 28;8(9):15407-15419. doi: 10.18632/oncotarget.14282.

Thrombospondin-1 up-regulates tumor cell invasion through the urokinase plasminogen activator receptor in head and neck cancer cells.

J Surg Res. 2004 Jul;120(1):21-6. doi: 10.1016/j.jss.2004.03.007.

uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgery.

Oncotarget. 2015 Jun 10;6(16):14260-73. doi: 10.18632/oncotarget.3680.

uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy.

Oncotarget. 2016 Aug 30;7(35):57351-57366. doi: 10.18632/oncotarget.10344.

Antibody-based PET of uPA/uPAR signaling with broad applicability for cancer imaging.

Oncotarget. 2016 Nov 8;7(45):73912-73924. doi: 10.18632/oncotarget.12528.

Image guided surgery in the management of head and neck cancer.

Oral Oncol. 2016 Jun;57:32-9. doi: 10.1016/j.oraloncology.2016.04.007. Epub 2016 Apr 25.

Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells.

Oncol Rep. 2007 May;17(5):1259-68.

Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues.

Cancer. 1996 Mar 15;77(6):1079-88. doi: 10.1002/(sici)1097-0142(19960315)77:6<1079::aid-cncr12>3.0.co;2-z.

Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalenesulfonate. Evidence for a hydrophobic binding site exposed only on the intact receptor.

Biochemistry. 1994 Aug 2;33(30):8991-7. doi: 10.1021/bi00196a017.

引用本文的文献

Side-by-Side Comparison of uPAR-Targeting Optical Imaging Antibodies and Antibody Fragments for Fluorescence-Guided Surgery of Solid Tumors.

Mol Imaging Biol. 2023 Feb;25(1):122-132. doi: 10.1007/s11307-021-01657-2. Epub 2021 Oct 12.

Fibrinolytic System and Cancer: Diagnostic and Therapeutic Applications.

Int J Mol Sci. 2021 Apr 22;22(9):4358. doi: 10.3390/ijms22094358.

Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer.

EJNMMI Res. 2020 Jul 28;10(1):87. doi: 10.1186/s13550-020-00673-7.

Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.

Front Oncol. 2018 Feb 12;8:24. doi: 10.3389/fonc.2018.00024. eCollection 2018.

本文引用的文献

Preclinical uPAR-targeted multimodal imaging of locoregional oral cancer.

Oral Oncol. 2017 Mar;66:1-8. doi: 10.1016/j.oraloncology.2016.12.026. Epub 2017 Jan 4.

uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model.

Oncotarget. 2017 Feb 28;8(9):15407-15419. doi: 10.18632/oncotarget.14282.

First-in-human uPAR PET: Imaging of Cancer Aggressiveness.

Theranostics. 2015 Sep 13;5(12):1303-16. doi: 10.7150/thno.12956. eCollection 2015.

uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgery.

Oncotarget. 2015 Jun 10;6(16):14260-73. doi: 10.18632/oncotarget.3680.

Identification of a new epitope in uPAR as a target for the cancer therapeutic monoclonal antibody ATN-658, a structural homolog of the uPAR binding integrin CD11b (αM).

PLoS One. 2014 Jan 21;9(1):e85349. doi: 10.1371/journal.pone.0085349. eCollection 2014.

Priorities of head and neck cancer patients: a patient survey based on the brief ICF core set for HNC.

Eur Arch Otorhinolaryngol. 2013 Nov;270(12):3133-42. doi: 10.1007/s00405-013-2446-8. Epub 2013 Mar 31.

Peptide-derived antagonists of the urokinase receptor. affinity maturation by combinatorial chemistry, identification of functional epitopes, and inhibitory effect on cancer cell intravasation.

Biochemistry. 2001 Oct 9;40(40):12157-68. doi: 10.1021/bi010662g.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验